Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × metarrestin × Clear all

NCT04222413 2026-04-24

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Phase 1 Recruiting

GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma